Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer

NCT01538537 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Solid Tumors
Cancer
Neoplasms

Interventions

DRUG: rigosertib sodium

Sponsor

Traws Pharma, Inc.